RNS Number: 5560 S Tate& Lyle PLC 07 November 2019 7 November 2019. TATE& LYLE PLC STATEMENT OF HALF YEAR RESULTS. ·Four-year US $100 m productivity programme on track.
RNS Number: 5915 O Tate& Lyle PLC 03 October 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3287 O Tate& Lyle PLC 01 October 2019 Tate& Lyle PLC. In accordance with Paragraph 5.6. 1 R of the Disclosure Guidance and Transparency Rules, Tate& Lyle PLC would like to notify the market of the following:. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Tate & Lyle Plc (TATE.L) Announced an agreement for a £930.00 million bulk annuity insurance 'buy-in' with Legal & General Assurance Society Limited. The agreement provides certainty and security for the Scheme's affected members. The buy-in secures an insurance asset from Legal & General that fully matches the remaining pension liabilities of the Scheme, with the result that the company no longer bears any investment, longevity, interest rate or inflation risk in respect of the Scheme. Under the transaction, the company will not contribute any incremental funding into the Scheme.
Agreement will deliver security for UK Scheme members while removing future risk for Tate& Lyle and saving £20 million of annual contributions. 19 September, 2019, London, UK: Tate& Lyle PLC and the Trustee of the Tate& Lyle Group Pension Scheme, the Group's UK pension scheme, today announce an agreement for a £930 million bulk annuity insurance' buy-in' with Legal&...
RNS Number: 4930 L Tate& Lyle PLC 06 September 2019. Notification of transaction by Person Discharging Managerial Responsibilities. Tate& Lyle PLC was informed that 15,064 ordinary shares of 25 pence each in the capital of the Company were released on 4 September 2019 to Andrew Taylor, a Person Discharging Managerial Responsibilities, in accordance with the...
RNS Number: 7215 K Tate& Lyle PLC 30 August 2019 Tate& Lyle PLC. Dr Ajai Puri, Non-Executive Director of Tate& Lyle PLC, has been appointed to the Board of Olam International Limited, a company listed on the Singapore stock exchange, as a Non-Executive Director, effective 1 September 2019.. RNS is approved by the Financial Conduct Authority to act as a Primary...
RNS Number: 6970 J Tate& Lyle PLC 21 August 2019. Tate& Lyle PLC was informed that 63,052 ordinary shares of 25 pence each in the capital of the Company were exercised on 19 August 2019 by Imran Nawaz, a Person Discharging Managerial Responsibilities, in accordance with the Restricted Share Award that was granted to him on 9 August 2018. 29,635 shares were withheld...
ISSUE OF DEBT- NOT FOR DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES OF SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.. $100 million 3.31% notes due 2029. $100 million 3.41% notes due 2031.
RNS Number: 5996 H Tate& Lyle PLC 01 August 2019 Tate& Lyle PLC. In accordance with Paragraph 5.6. 1 R of the Disclosure Guidance and Transparency Rules, Tate& Lyle PLC would like to notify the market of the following:. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7511 G Tate& Lyle PLC 25 July 2019 Tate& Lyle PLC. Result of Annual General Meeting 2019. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 0131 G Tate& Lyle PLC 18 July 2019 Tate& Lyle PLC. Tate& Lyle PLC announces that a grant of options and awards over ordinary shares of 25 pence each in the capital of the Company was made on 17 July 2019 under the Tate& Lyle Performance Share Plan 2012 in respect of the year ended 31 March 2019. Additionally, the Company was informed that on 17 July 2019, Jim...
RNS Number: 7332 F Tate& Lyle PLC 17 July 2019. Tate& Lyle announces departure of President, Food& Beverage Solutions. Tate& Lyle PLC announces that Joan Braca, President, Food& Beverage Solutions will be leaving Tate& Lyle on 30 August 2019 to take up a new role as Sector Chief Executive, Clean Air at Johnson Matthey Plc..
RNS Number: 0542 E Tate& Lyle PLC 01 July 2019. BLOCK LISTING SIX MONTHLY RETURN. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 0530 E Tate& Lyle PLC 01 July 2019 Tate& Lyle PLC. In accordance with Paragraph 5.6. 1 R of the Disclosure Guidance and Transparency Rules, Tate& Lyle PLC would like to notify the market of the following:. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 0393 E Tate& Lyle PLC 01 July 2019 Tate& Lyle PLC. Tate& Lyle PLC was informed that on 26 June 2019, Joan Braca, a Person Discharging Managerial Responsibilities was allotted 3,703 ordinary shares of 25 pence each in the capital of the Company under the Tate& Lyle 2011 Sharesave Scheme at an option price of 486.00 pence per share. RNS is approved by the...
RNS Number: 6878 B Tate& Lyle PLC 10 June 2019 Tate& Lyle PLC. Tate& Lyle PLC confirms that copies of the following documents have been submitted to the National Storage Mechanism and will shortly be available for inspection at: Notice of Annual General Meeting 2019;.
RNS Number: 2151 B Tate& Lyle PLC 05 June 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2144 B Tate& Lyle PLC 05 June 2019. Tate& Lyle PLC announces that on 3 June 2019 the following transactions occurred by Persons Discharging Managerial Responsibilities in respect of their interests in ordinary shares of 25 pence each in the capital of the Company under the Tate& Lyle Group Bonus Plan, and the 2012 Performance Share Plan.
RNS Number: 9355 A Tate& Lyle PLC 03 June 2019 Tate& Lyle PLC. In accordance with Paragraph 5.6. 1 R of the Disclosure Guidance and Transparency Rules, Tate& Lyle PLC would like to notify the market of the following:. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Tate & Lyle Plc
TATE.L
Tate & Lyle Plc
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    467.52M

Company Profile

Tate & Lyle produces an estimated 4m tonnes of cereal sweeteners and refines over 2m tonnes of sugar each year sold into around 35 countries. It is is a global leader in cereal sweeteners and starches, sugar refining, value added food and industrial ingredients and citric acid. It is world number one in industrial starches and wheat proteins and the sole manufacturer of sucralose sugar substitute, Splenda.

Classification

Market Indices-

Locations

HQ
1 Kingsway
London
WC2B 6AT
Watchlist